Crippa Stefano Professore AssociatoMedicineMED/18 - Chirurgia Generale




Assistant Professor of Surgery


2003: MD, cum laude, University of Milano-Bicocca, Milan, Italy

2006–2007: Research Fellow in Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, USA - Mentors: Carlos Fernandez-del CastIllo & Andrew L. Warshaw

2004-2009: Residency in Surgery, University of  Verona, Verona, Italy

2010-2013: PhD in Neoplastic and Inflammatory Diseases of the Pancreas, Liver and Biliary Ducts, University of  Verona, Verona, Italy – Mentors: Massimo Falconi & Claudio Bassi


2010-2012: Attending Surgeon, Division of General Surgery, Ospedale Sacro Cuore, Negrar (VR), Italy -  Chief: Prof. Massimo Falconi

2012-2014: Attending Surgeon, Division of Pancreatic Surgery, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria “Ospedali Riuniti”, Ancona, Italy - Chief: Prof. Massimo Falconi

2015-present: Attending Surgeon, Division of Pancreatic Surgery, San Raffaele Scientific Institute, Milan, Italy - Chief: Prof. Massimo Falconi

2018-present: Assistant Professor of Surgery, Vita Salute San Raffaele University, Milan, Italy


Multimodal treatment of pancreatic tumors (pancreatic ductal adenocarcinoma, cystic neoplasms/intraductal papillary mucinous neoplasms, neuroendocrine tumors); open and minimally invasive surgery of pancreas and biliary tree; acute and chronic pancreatitis; familial pancreatic cancer; upper GI tract surgery; hernia; emergency and trauma surgery (Division of Emergency Surgery, San Raffaele Scientific Institute); surveillance of cystic neoplasms of the pancreas

Dr Crippa performed more than 1200 surgical procedure sas first operator/tutor, mainly in the setting of pancreatic surgery


Dr Crippa is first author or co-author of 160 peer-reviewed paper -  H index (Scopus): 41, total number of citations > 6000.

Research interests:

  1. Prognostic factors and therapeutic strategies for the management of pancreatic cancer and IPMNs
  2. Translational research applied to pancreatic cancer and IPMNs;
  3. Identification of new biomarkers of malignancy in pancreatic cystic lesions
  4. Risk factors for complications after pancreatic surgery
  5. Application of minimally invasive surgery in pancreatic surgery


1.            Member of working group of Italian Guidelines for the diagnosis and work up of cystic neoplasms of the pancreas:

Italian Association of Hospital Gastroenterologists and Endoscopists, AIGO and Italian Association for the Study of the Pancreas, AISP, Buscarini E, et al. Italian consensus guidelines for the diagnostic  work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis 2014;46:479-93

2.            Member of working group of Italian Guidelines on acute pancreatitis

Italian Association for the Study of the Pancreas (AISP), Pezzilli R, et al. Consensus guidelines on severe acute pancreatitis. Dig Liver Dis 2015;47:532-543

3.            Member of working group of Italian Association of Medical Oncology (AIOM) for pancreatic cancer guidelines  (2017-present):


Italian Surgical Association

Italian Association for the Study of the Pancreas (Council 2014-2017)

Society for Surgery of the Alimentary Tract (International Relations Committee 2016-2018)

International Hepato-Pancreato-Biliary Association (IHPBA)

The Pancreas Club

International Association of Pancreatology (IAP)

European Pancreatic Club (EPC)


Member of the Editorial Board of the following journals:

2009-present:   World Journal of Gastrointestinal Surgery

2010-2016:                          Langenbeck's Archives of Surgery

2015-present:                   Medicine (Academic Editor)

2018-presente                 PlosOne (Academic Editor)

Reviewer for the following journals:



Annals of Surgery

American Journal of Gastroenterology

British Journal of Surgery


Journal of Proteomics

BMC Cancer

Digestive and Liver Disease

Digestive Diseases

Digestive Surgery



World Journal of Gastroenterology

World Journal of Surgical Oncology

International Journal of Endocrine Oncology

Expert Review of Gastroenterology and Hepatology

Expert Review of Anticancer Treatment

Expert Review on Therapeutic Targets

Hepatobiliary & Pancreatic Diseases International

Journal of Laparoscopy, Endoscopy and Percutaneous Techniques


2006:                     Kenneth Warren International Fellowship Award

                               International Hepato-Pancreato-Biliary Association

2010:                     Premio “Ettore Ruggieri” 2009 – Italian Society for Surgery

2017:                     UEG Rising Star Award - United European Gastroenterology

Best oral comunications during meetings:

2007:                     Massachusetts Surgical Society

2nd Prize Residents and Fellows Conference

Boston, Ma, USA

2007:                     Selected Best Oral Communication

                               48th Meeting of the Society for Surgery of the Alimentary Tract

                               22nd  Annual SSAT Residents and Fellows Research Conference

                               Washington DC, USA

2016:                     Best Scientific Publication 2015

                               Italian Society of Gastroenterology (SIGE)

2016:                     John Howard Annual Research Award

                               50th Annual Pancreas Club Meeting

San Diego, Ca, USA


2016                      Ricerca Finalizzata Bando Giovani Ricercatori 2016– Italian Ministry of Health

“Genomic mechanisms of pancreatic cancer-induced human neutrophil reprogramming: implications for early management of premalignant lesions”.

                                Co-PI and Leader Unit 2-Pancreatic Surgery,  San Raffaele Scientific Institute, Milan

                               Overall budget: 450000 euro (Budget Unit 2: 75000 euro)

2018                      Ricerca Finalizzata Bando Giovani Ricercatori 2018– Italian Ministry of Health

“Definition of radiological and endocrine/metabolic/inflammatory biomarker(s) to identify high grade dysplasia/invasive carcinoma in patients with intraductal papillary mucinous neoplasms of the pancreas”

PI and Leader Unit 1 Pancreatic Surgery,  San Raffaele Scientific Institute, Milan

Overall budget: 450000 euro (Budget Unit 1: 210000 euro)

2018-2020:          Grant from “Fondazione Nadia Valsecchi” for the study of inflammation in IPMNs

Overall budget: 60000 euro (20000 euro/year)


1: Pergolini I, Crippa S, Pagnanelli M, Belfiori G, Pucci A, Partelli S, Rubini C, Castelli P, Zamboni G, Falconi M. Prognostic impact of Ki-67 proliferative index in resectable pancreatic ductal adenocarcinoma. BJS Open. 2019 May 10;3(5):646-655. doi: 10.1002/bjs5.50175. eCollection 2019 Oct. PubMed PMID: 31592095; PubMed Central PMCID: PMC6773637.

2: Springer S, Masica DL, Dal Molin M, Douville C, Thoburn CJ, Afsari B, Li L, Cohen JD, Thompson E, Allen PJ, Klimstra DS, Schattner MA, Schmidt CM, Yip-Schneider M, Simpson RE, Fernandez-Del Castillo C, Mino-Kenudson M, Brugge W, Brand RE, Singhi AD, Scarpa A, Lawlor R, Salvia R, Zamboni G, Hong SM, Hwang DW,  Jang JY, Kwon W, Swan N, Geoghegan J, Falconi M, Crippa S, Doglioni C, Paulino J, Schulick RD, Edil BH, Park W, Yachida S, Hijioka S, van Hooft J, He J, Weiss MJ,  Burkhart R, Makary M, Canto MI, Goggins MG, Ptak J, Dobbyn L, Schaefer J, Sillman N, Popoli M, Klein AP, Tomasetti C, Karchin R, Papadopoulos N, Kinzler KW, Vogelstein B, Wolfgang CL, Hruban RH, Lennon AM. A multimodality test to guide the management of patients with a pancreatic cyst. Sci Transl Med. 2019 Jul 17;11(501). pii: eaav4772. doi: 10.1126/scitranslmed.aav4772. PubMed PMID: 31316009.

3: Paiella S, Capurso G, Cavestro GM, Butturini G, Pezzilli R, Salvia R, Signoretti M, Crippa S, Carrara S, Frigerio I, Bassi C, Falconi M, Iannicelli E,  Giardino A, Mannucci A, Laghi A, Laghi L, Frulloni L, Zerbi A. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry. Am J Gastroenterol. 2019 Apr;114(4):665-670. doi: 10.1038/s41395-018-0414-z. PubMed PMID: 30538291.

4: Petrone MC, Magnoni P, Pergolini I, Capurso G, Traini M, Doglioni C, Mariani  A, Crippa S, Arcidiacono PG. Long-term follow-up of low-risk branch-duct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature? Clin Transl Gastroenterol. 2018 Jun 13;9(6):158. doi: 10.1038/s41424-018-0026-3. Erratum in: Clin Transl Gastroenterol. 2018 Aug 1;9(7):173. PubMed PMID: 29895904; PubMed Central PMCID: PMC5997632.

5: Partelli S, Bertani E, Bartolomei M, Perali C, Muffatti F, Grana CM, Schiavo  Lena M, Doglioni C, Crippa S, Fazio N, Zamboni G, Falconi M. Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms. Surgery. 2018 Apr;163(4):761-767. doi: 10.1016/j.surg.2017.11.007. Epub 2017 Dec 25. PubMed PMID: 29284590.

6: Crippa S, Cirocchi R, Maisonneuve P, Partelli S, Pergolini I, Tamburrino D, Aleotti F, Reni M, Falconi M. Systematic review and meta-analysis of prognostic role of splenic vessels infiltration in resectable pancreatic cancer. Eur J Surg  Oncol. 2018 Jan;44(1):24-30. doi: 10.1016/j.ejso.2017.10.217. Epub 2017 Nov 20. Review. PubMed PMID: 29183639.

7: Reni M, Zanon S, Balzano G, Nobile S, Pircher CC, Chiaravalli M, Passoni P, Arcidiacono PG, Nicoletti R, Crippa S, Slim N, Doglioni C, Falconi M, Gianni L. Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma. Ann Oncol. 2017 Nov 1;28(11):2786-2792. doi: 10.1093/annonc/mdx495. PubMed PMID: 28945895.

8: Sohal DPS, Willingham FF, Falconi M, Raphael KL, Crippa S. Pancreatic Adenocarcinoma: Improving Prevention and Survivorship. Am Soc Clin Oncol Educ Book. 2017;37:301-310. doi: 10.14694/EDBK_175222. Review. PubMed PMID: 28561672.

9: Crippa S, Pezzilli R, Bissolati M, Capurso G, Romano L, Brunori MP, Calculli  L, Tamburrino D, Piccioli A, Ruffo G, Fave GD, Falconi M. Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative Management. Am J Gastroenterol. 2017  Jul;112(7):1153-1161. doi: 10.1038/ajg.2017.43. Epub 2017 Feb 28. PubMed PMID: 28244498.

10: Partelli S, Cirocchi R, Crippa S, Cardinali L, Fendrich V, Bartsch DK, Falconi M. Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms. Br J Surg. 2017 Jan;104(1):34-41. doi: 10.1002/bjs.10312. Epub 2016 Oct 5. Review. PubMed PMID: 27706803.

11: Crippa S, Bittoni A, Sebastiani E, Partelli S, Zanon S, Lanese A, Andrikou K, Muffatti F, Balzano G, Reni M, Cascinu S, Falconi M. Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to  chemotherapy? Eur J Surg Oncol. 2016 Oct;42(10):1533-9. doi: 10.1016/j.ejso.2016.06.398. Epub 2016 Jun 29. PubMed PMID: 27423449.

12: Crippa S, Reni M, Balzano G, Doglioni C, Falconi M. Justifying vein resection with pancreatoduodenectomy. Lancet Oncol. 2016 May;17(5):e177-8. doi: 10.1016/S1470-2045(16)30037-7. Epub 2016 Apr 27. PubMed PMID: 27301040.

13: Crippa S, Cirocchi R, Randolph J, Partelli S, Belfiori G, Piccioli A, Parisi  A, Falconi M. Pancreaticojejunostomy is comparable to pancreaticogastrostomy after pancreaticoduodenectomy: an updated meta-analysis of randomized controlled  trials. Langenbecks Arch Surg. 2016 Jun;401(4):427-37. doi: 10.1007/s00423-016-1418-z. Epub 2016 Apr 21. Review. PubMed PMID: 27102322.

14: Crippa S, Capurso G, Cammà C, Fave GD, Castillo CF, Falconi M. Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis. Dig Liver Dis. 2016 May;48(5):473-479. doi: 10.1016/j.dld.2016.02.003. Epub 2016 Feb 18. Review. PubMed PMID: 26965783.

15: Crippa S, Bassi C, Salvia R, Malleo G, Marchegiani G, Rebours V, Levy P, Partelli S, Suleiman SL, Banks PA, Ahmed N, Chari ST, Fernández-Del Castillo C, Falconi M. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a  mid-term follow-up analysis. Gut. 2017 Mar;66(3):495-506. doi: 10.1136/gutjnl-2015-310162. Epub 2016 Jan 7. PubMed PMID: 26743012.

16: Crippa S, Pergolini I, Rubini C, Castelli P, Partelli S, Zardini C, Marchesini G, Zamboni G, Falconi M. Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms. Surgery. 2016 Apr;159(4):1041-9. doi: 10.1016/j.surg.2015.11.003. Epub 2015 Dec 17. PubMed PMID: 26704784.

17: Sahora K, Crippa S, Zamboni G, Ferrone C, Warshaw AL, Lillemoe K, Mino-Kenudson M, Falconi M, Fernandez-del Castillo C. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms. Eur J Surg Oncol. 2016 Feb;42(2):197-204. doi: 10.1016/j.ejso.2015.10.014. Epub 2015 Dec 1. PubMed PMID: 26687069.

18: Crippa S, Partelli S, Bassi C, Berardi R, Capelli P, Scarpa A, Zamboni G, Falconi M. Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters. Surgery. 2016 Mar;159(3):862-71. doi: 10.1016/j.surg.2015.09.012. PubMed PMID: 26602841.

19: Falconi M, Crippa S, Chari S, Conlon K, Kim SW, Levy P, Tanaka M, Werner J, Wolfgang CL, Pezzilli R, Castillo CF. Quality assessment of the guidelines on cystic neoplasms of the pancreas. Pancreatology. 2015 Sep-Oct;15(5):463-469. doi: 10.1016/j.pan.2015.05.478. Epub 2015 Jun 12. Review. PubMed PMID: 26100659.

20: Jais B, Rebours V, Malleo G, Salvia R, Fontana M, Maggino L, Bassi C, Manfredi R, Moran R, Lennon AM, Zaheer A, Wolfgang C, Hruban R, Marchegiani G, Fernández Del Castillo C, Brugge W, Ha Y, Kim MH, Oh D, Hirai I, Kimura W, Jang JY, Kim SW, Jung W, Kang H, Song SY, Kang CM, Lee WJ, Crippa S, Falconi M, Gomatos I, Neoptolemos J, Milanetto AC, Sperti C, Ricci C, Casadei R, Bissolati M, Balzano G, Frigerio I, Girelli R, Delhaye M, Bernier B, Wang H, Jang KT, Song  DH, Huggett MT, Oppong KW, Pererva L, Kopchak KV, Del Chiaro M, Segersvard R, Lee LS, Conwell D, Osvaldt A, Campos V, Aguero Garcete G, Napoleon B, Matsumoto I, Shinzeki M, Bolado F, Fernandez JM, Keane MG, Pereira SP, Acuna IA, Vaquero EC, Angiolini MR, Zerbi A, Tang J, Leong RW, Faccinetto A, Morana G, Petrone MC, Arcidiacono PG, Moon JH, Choi HJ, Gill RS, Pavey D, Ouaïssi M, Sastre B, Spandre  M, De Angelis CG, Rios-Vives MA, Concepcion-Martin M, Ikeura T, Okazaki K, Frulloni L, Messina O, Lévy P. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut. 2016 Feb;65(2):305-12. doi: 10.1136/gutjnl-2015-309638. Epub 2015 Jun 4. PubMed PMID: 26045140.

21: Italian Association of Hospital Gastroenterologists and Endoscopists; Italian Association for the Study of the Pancreas, Buscarini E, Pezzilli R, Cannizzaro R, De Angelis C, Gion M, Morana G, Zamboni G, Arcidiacono P, Balzano G, Barresi L, Basso D, Bocus P, Calculli L, Capurso G, Canzonieri V, Casadei R, Crippa S, D'Onofrio M, Frulloni L, Fusaroli P, Manfredi G, Pacchioni D, Pasquali C, Rocca R, Ventrucci M, Venturini S, Villanacci V, Zerbi A, Falconi M; Cystic Pancreatic  Neoplasm Study Group. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis. 2014 Jun;46(6):479-93. doi: 10.1016/j.dld.2013.12.019. Epub 2014 May 5. PubMed PMID: 24809235.

22: Crippa S, Salgarello M, Laiti S, Partelli S, Castelli P, Spinelli AE, Tamburrino D, Zamboni G, Falconi M. The role of (18)fluoro-deoxyglucose positron  emission tomography/computed tomography in resectable pancreatic cancer. Dig Liver Dis. 2014 Aug;46(8):744-9. doi: 10.1016/j.dld.2014.03.011. Epub 2014 Apr 8. PubMed PMID: 24721105.

23: Crippa S, Partelli S, Zamboni G, Scarpa A, Tamburrino D, Bassi C, Pederzoli P, Falconi M. Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors. Surgery. 2014 Jan;155(1):145-53. doi: 10.1016/j.surg.2013.08.002. PubMed PMID: 24646958.

24: Nones K, Waddell N, Song S, Patch AM, Miller D, Johns A, Wu J, Kassahn KS, Wood D, Bailey P, Fink L, Manning S, Christ AN, Nourse C, Kazakoff S, Taylor D, Leonard C, Chang DK, Jones MD, Thomas M, Watson C, Pinese M, Cowley M, Rooman I,  Pajic M; APGI, Butturini G, Malpaga A, Corbo V, Crippa S, Falconi M, Zamboni G, Castelli P, Lawlor RT, Gill AJ, Scarpa A, Pearson JV, Biankin AV, Grimmond SM. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8. doi: 10.1002/ijc.28765. Epub 2014 May 9. PubMed PMID: 24500968.

25: Partelli S, Gaujoux S, Boninsegna L, Cherif R, Crippa S, Couvelard A, Scarpa  A, Ruszniewski P, Sauvanet A, Falconi M. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). JAMA Surg. 2013 Oct;148(10):932-9. doi: 10.1001/jamasurg.2013.3376. PubMed PMID:  23986355.

26: Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C, Nagrial AM, Chantrill LA, Chin VT, Pinho AV, Rooman I, Cowley MJ, Wu J, Mead RS, Colvin EK, Samra JS, Corbo V, Bassi C, Falconi M, Lawlor RT, Crippa S, Sperandio N, Bersani S, Dickson EJ, Mohamed MA, Oien KA, Foulis AK, Musgrove EA, Sutherland RL, Kench JG, Carter CR, Gill AJ, Scarpa A, McKay CJ, Biankin AV. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. J Clin Oncol. 2013 Apr 1;31(10):1348-56.  doi: 10.1200/JCO.2012.46.8868. Epub 2013 Feb 25. PubMed PMID: 23439753.

27: Crippa S, Partelli S, Falconi M. Rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012 Jul 19;367(3):278; author reply 278-9. doi: 10.1056/NEJMc1205928. PubMed PMID: 22808974.

28: Crippa S, Partelli S, Zamboni G, Barugola G, Capelli P, Inama M, Bassi C, Pederzoli P, Falconi M. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile? Surgery. 2012 Sep;152(3 Suppl 1):S112-9. doi: 10.1016/j.surg.2012.05.017. Epub 2012 Jul 3. PubMed PMID: 22766365.

29: Crippa S, Zerbi A, Boninsegna L, Capitanio V, Partelli S, Balzano G, Pederzoli P, Di Carlo V, Falconi M. Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. Arch Surg. 2012 Mar;147(3):261-6. doi: 10.1001/archsurg.2011.1843. PubMed PMID: 22430908 (now JAMA Surgery)

30: Partelli S, Crippa S, Barugola G, Tamburrino D, Capelli P, D'Onofrio M, Pederzoli P, Falconi M. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection. Ann Surg Oncol. 2011 Dec;18(13):3608-14. doi: 10.1245/s10434-011-1769-1. Epub 2011 May 17. PubMed PMID: 21584836.

31: Butturini G, Partelli S, Crippa S, Malleo G, Rossini R, Casetti L, Melotti GL, Piccoli M, Pederzoli P, Bassi C. Perioperative and long-term results after left pancreatectomy: a single-institution, non-randomized, comparative study between open and laparoscopic approach. Surg Endosc. 2011 Sep;25(9):2871-8. doi:  10.1007/s00464-011-1634-0. Epub 2011 Mar 18. PubMed PMID: 21424200.

32: Bassi C, Molinari E, Malleo G, Crippa S, Butturini G, Salvia R, Talamini G,  Pederzoli P. Early versus late drain removal after standard pancreatic resections: results of a prospective randomized trial. Ann Surg. 2010 Aug;252(2):207-14. doi: 10.1097/SLA.0b013e3181e61e88. PubMed PMID: 20622661.

33: Crippa S, Tamburrino D, Partelli S, Salvia R, Germenia S, Bassi C, Pederzoli P, Falconi M. Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. Surgery. 2011 Jan;149(1):79-86. doi: 10.1016/j.surg.2010.04.007. Epub 2010 May 21. PubMed PMID: 20494386.

34: Crippa S, Fernández-Del Castillo C, Salvia R, Finkelstein D, Bassi C, Domínguez I, Muzikansky A, Thayer SP, Falconi M, Mino-Kenudson M, Capelli P, Lauwers GY, Partelli S, Pederzoli P, Warshaw AL. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol. 2010 Feb;8(2):213-9. doi: 10.1016/j.cgh.2009.10.001. Epub 2009 Oct 14. PubMed PMID: 19835989; PubMed Central PMCID: PMC3135334.

35: Crippa S, Salvia R, Warshaw AL, Domínguez I, Bassi C, Falconi M, Thayer SP,  Zamboni G, Lauwers GY, Mino-Kenudson M, Capelli P, Pederzoli P, Castillo CF. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg. 2008 Apr;247(4):571-9. doi: 10.1097/SLA.0b013e31811f4449. PubMed PMID: 18362619; PubMed Central PMCID: PMC3806104.

36: Rodriguez JR, Salvia R, Crippa S, Warshaw AL, Bassi C, Falconi M, Thayer SP, Lauwers GY, Capelli P, Mino-Kenudson M, Razo O, McGrath D, Pederzoli P, Fernández-Del Castillo C. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007 Jul;133(1):72-9; quiz 309-10. Epub 2007 May 10. PubMed PMID: 17631133; PubMed Central PMCID: PMC3807096.

37: Crippa S, Bassi C, Warshaw AL, Falconi M, Partelli S, Thayer SP, Pederzoli P, Fernández-del Castillo C. Middle pancreatectomy: indications, short- and long-term operative outcomes. Ann Surg. 2007 Jul;246(1):69-76. PubMed PMID: 17592293; PubMed Central PMCID: PMC1899210.

38: Crippa S, Bassi C, Salvia R, Falconi M, Butturini G, Pederzoli P. Enucleation of pancreatic neoplasms. Br J Surg. 2007 Oct;94(10):1254-9. PubMed PMID: 17583892.

39: Salvia R, Crippa S, Falconi M, Bassi C, Guarise A, Scarpa A, Pederzoli P. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate  or not to operate? Gut. 2007 Aug;56(8):1086-90. Epub 2006 Nov 24. PubMed PMID: 17127707; PubMed Central PMCID: PMC1955529.

40: Staudacher C, Orsenigo E, Baccari P, Di Palo S, Crippa S. Laparoscopic assisted duodenopancreatectomy. Surg Endosc. 2005 Mar;19(3):352-6. Epub 2004 Dec  2. PubMed PMID: 15627172.

Il titolare del presente curriculum vitae, pubblicato online sul portale, è garante in via esclusiva della correttezza e della veridicità dei dati e delle informazioni in esso riportate e del loro eventuale e puntuale aggiornamento. Egli è dunque il diretto ed unico responsabile dei contenuti indicati nei propri curricula.